Acorah Software Products - Accounts Production 16.1.300 false true 31 January 2024 1 February 2023 false 1 February 2024 31 January 2025 31 January 2025 09975459 Mrs Bernita Appiah Dr Kwasi Appiah iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09975459 2024-01-31 09975459 2025-01-31 09975459 2024-02-01 2025-01-31 09975459 frs-core:CurrentFinancialInstruments 2025-01-31 09975459 frs-core:FurnitureFittings 2025-01-31 09975459 frs-core:FurnitureFittings 2024-02-01 2025-01-31 09975459 frs-core:FurnitureFittings 2024-01-31 09975459 frs-core:ShareCapital 2025-01-31 09975459 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31 09975459 frs-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09975459 frs-bus:FilletedAccounts 2024-02-01 2025-01-31 09975459 frs-bus:SmallEntities 2024-02-01 2025-01-31 09975459 frs-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 09975459 frs-bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 09975459 frs-bus:Director1 2024-02-01 2025-01-31 09975459 frs-bus:Director2 2024-02-01 2025-01-31 09975459 frs-countries:EnglandWales 2024-02-01 2025-01-31 09975459 2023-01-31 09975459 2024-01-31 09975459 2023-02-01 2024-01-31 09975459 frs-core:CurrentFinancialInstruments 2024-01-31 09975459 frs-core:ShareCapital 2024-01-31 09975459 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31
Registered number: 09975459
Bekap Medical Limited
Financial Statements
For The Year Ended 31 January 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 09975459
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 113 150
113 150
CURRENT ASSETS
Debtors 5 - 1,567
Cash at bank and in hand 7,748 8,648
7,748 10,215
Creditors: Amounts Falling Due Within One Year 6 (7,687 ) (10,180 )
NET CURRENT ASSETS (LIABILITIES) 61 35
TOTAL ASSETS LESS CURRENT LIABILITIES 174 185
NET ASSETS 174 185
CAPITAL AND RESERVES
Called up share capital 7 101 101
Profit and Loss Account 73 84
SHAREHOLDERS' FUNDS 174 185
Page 1
Page 2
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Kwasi Appiah
Director
28 February 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Bekap Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09975459 . The registered office is Damer House, Meadow Way, Wickford, Essex, SS12 9HA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added taxes, and other similar allowances.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25% Reducing balance
2.4. Taxation
Taxation represents the sum of the tax currently payable and deferred tax.
The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
The average number of employees, including directors, during the year was as follows: 3 (2024: 3)
3 3
Page 3
Page 4
4. Tangible Assets
Fixtures & Fittings
£
Cost
As at 1 February 2024 1,500
As at 31 January 2025 1,500
Depreciation
As at 1 February 2024 1,350
Provided during the period 37
As at 31 January 2025 1,387
Net Book Value
As at 31 January 2025 113
As at 1 February 2024 150
5. Debtors
2025 2024
£ £
Due within one year
Other debtors - 1,567
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Other creditors 4,041 6,028
Taxation and social security 3,646 4,152
7,687 10,180
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 101 101
Page 4